Residual Drug in Transdermal and Related Drug Delivery Systems; Availability
Title: Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
This is comment on Notice
Residual Drug in Transdermal and Related Drug Delivery Systems; Availability
View Comment
Attachments:
Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Title:
Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Related Comments
View AllPublic Submission Posted: 10/27/2010 ID: FDA-2010-D-0246-0003
Nov 01,2010 11:59 PM ET
Public Submission Posted: 10/27/2010 ID: FDA-2010-D-0246-0005
Nov 01,2010 11:59 PM ET
Public Submission Posted: 11/02/2010 ID: FDA-2010-D-0246-0006
Nov 01,2010 11:59 PM ET
Public Submission Posted: 11/02/2010 ID: FDA-2010-D-0246-0007
Nov 01,2010 11:59 PM ET
Public Submission Posted: 11/02/2010 ID: FDA-2010-D-0246-0008
Nov 01,2010 11:59 PM ET